Clinical Trial Failure Isn’t an Inevitable Risk—It’s Insurable and Opening the Door to New Investors
Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for funding and innovation.
Natalie Marquess, ARM, CIC, CRM
Advertisement
Director - Business Development, Life Sciences at Aon
Articles by Natalie Marquess, ARM, CIC, CRM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
HHS Launches SURPASS Program and Three Complementary Initiatives to Transform Clinical Trial Design and Infrastructure
2
The Control Plane for Agentic Clinical Operations: Governing Autonomous Digital Actors in Regulated Trials
3
Where AI Leads in Trial Design—and Where Humans Still Need To
4
ACT Brief: Proactive Trial Risk Management, Federal Infrastructure Modernization, Pediatric Heart Disease Treatment
5